Risk Analysis · 1998 · 28 citations · 8 references
PharmacyPharmacologyToxicologyComparative ToxicologyMechanisms Of ToxicityToxicodynamicsDose-exposure RelationshipsDose-response AssessmentDose-response RelationshipsSpecies Differences In ToxicityBody Mass EffectsCross-species Dose-response RelationshipsLethal Dose ComparisonScaling Across SpeciesSpecies Comparison Of ToxicitySpecies Dose-response ComparisonsSpecies-specific Dose DeterminationToxicity In Animals
The scaling of administered doses to achieve equal degrees of toxic effect in different species has been relatively poorly examined for noncancer toxicity, either empirically or theoretically. We investigate empirical patterns in the correspondence of single oral dose LD50 values across several mammalian species for a large number of chemicals based on data reported in the RTECS database maintained by the National Institute for Occupational Safety and Health. We find a good correspondence of LD50 values across species when the dose levels are expressed in terms of mg administered per kg of body mass. Our findings contrast with earlier analyses that support scaling doses by the 3/4-power of body mass to achieve equal subacute toxicity of antineoplastic agents. We suggest that, especially for severe toxicity, single- and repeated-dosing regimes may have different cross-species scaling properties, as they may depend on standing levels of defenses and rate of regeneration of defenses, respectively.
8
Man versus Beast: Pharmacokinetic Scaling in Mammals
Joyce Mordenti · Journal of Pharmaceutical Sciences · 1986 · 390 citations
Interspecific Scaling of Toxicity Data
Curtis C. Travis, R.K. White · Risk Analysis · 1988 · 110 citations
Pharmacy, Oncology, Toxicology +16